Healthcare -
Biotechnology - NASDAQ - US
$ 4.1375
-0.541 %
$ 86.1 M
Market Cap
-0.7
P/E
ADVM - RESEARCH & DEVELOPMENT
Research & Development ADVM - Adverum Biotechnologies, Inc.
77.5 M
LAST VALUE
-6.79%
2 YEAR CAGR
9.10%
5 YEAR CAGR
43.10%
10 YEAR CAGR